Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Bioorg Med Chem Lett. 2021 Jan 28;37:127809. doi: 10.1016/j.bmcl.2021.127809

Trivalent Sulfonium Compounds (TSCs): Tetrahydrothiophene-based amphiphiles exhibit similar antimicrobial activity to analogous ammonium-based amphiphiles

Javier A Feliciano a, Austin J Leitgeb a, Cassandra L Schrank b, Ryan A Allen b, Kevin P C Minbiole a, William M Wuest b, Robert G Carden a
PMCID: PMC7965331  NIHMSID: NIHMS1669596  PMID: 33516911

Abstract

Recent advances in the development of quaternary ammonium compounds (QACs) have focused on new structural motifs to increase bioactivity, but significantly less studied has been the change from ammonium- to sulfonium-based disinfectants. Herein, we report the synthesis of structurally analogous series of quaternary ammonium and trivalent sulfonium compounds (TSCs). The bioactivity profiles of these compounds generally mirror each other, and the antibacterial activity of sulfonium-based THT-18 was found to be comparable to the commercial disinfectant, BAC. The development of these compounds presents a new avenue for further study of disinfectants to combat the growing threat of bacterial resistance.

Keywords: antiseptics, trivalent sulfonium compounds, methicillin-resistant Staphylococcus aureus (MRSA), quaternary ammonium compounds, benzalkonium chloride

Graphical Abstract

graphic file with name nihms-1669596-f0001.jpg


Quaternary ammonium compounds (QACs) have been commonplace in the past century as a simple means to combat bacterial infections, being found as the active ingredients in disinfecting sprays and mouthwashes.[1,2] To prevent bacterial infection, QACs bind to bacterial cell surfaces via the positively charged nitrogen atom allowing the long aliphatic chains to disrupt the membrane, leading to cell lysis and bacterial death.[3] Due to their robust structure, QACs have found their way into the environment in low concentrations, and bacterial strains have begun to develop resistance to common commercial disinfectants at an alarming rate.[4] To address this concern, there has been a recent resurgence in the study of QAC developmeent. Of particular interest has been the investigation of key structure-activity relationships of these amphiphilic compounds. This has allowed for the generation of QACs that are quite effective against a wide range of both Gram-negative and Gram-positive bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA).[511]

From the recent development of novel QACs, trends have emerged regarding structural motifs that increase the bioactivity profiles of these compounds, including the ratio of polar to nonpolar regions as well as the number of positively charged nitrogen atoms.[4,12,13] Less studied, however, are the effects of changing the atom that holds the formal positive charge, typically at the core of the structure. Amphiphilic compounds with phosphonium cations acting as the polar group have been reported; some of these showed superior activity against bacterial strains versus similar nitrogen-based QACs.[1418] There are even fewer reports of amphiphilic compounds bearing trivalent sulfonium moieties as the polar group. A review of these developments has recently been published.[19]

Sulfonium compounds are prevalent in both plants[20] and animals,[21] one of the most prevalent being S-adenosyl-methionine (SAM). SAM has been utilized as therapeutic to treat depression,[22] osteoarthritis,[23] liver disease,[24] and even as a dietary supplement.[25] The bioactivity of sulfonium compounds as antiseptics, however, has been understudied, therefore offering a unique avenue to expand upon the structural diversity of current amphiphilic antiseptics.[2629] The incorporation of a sulfonium moiety as a modification has led to promising increases in bioactivity in antimicrobial compounds that are not otherwise amphiphilic. In a recent example, the addition of a sulfonium group to vancomycin increased bioactivity against Gram-positive resistant bacteria (Figure 1A).[30] Similarly, N-chloramines exhibited enhanced inhibitory effects upon the addition of lipophilic sulfonium moieties (Figure 1B). In both cases, the observed increase in activity was attributed to the amphiphilic nature of the sulfonium moiety leading to membrane disruption and eventual cell lysis.[30,31]

Figure 1.

Figure 1.

Examples of known amphiphilic sulfonium compounds with antibacterial activity: A) vancomycin derivative with appended sulfonium moiety,[30] (B) N-chloramine with appended sulfonium group[31] and (C) bioactive trialkyl and -aryl sulfonium compounds.[3234]

Few sulfonium-based amphiphiles, herein defined as trivalent sulfonium compounds (TSCs), made up of simple aliphatic groups have been previously reported. Hirayama reported symmetrically substituted alkyl and aryl TSCs bearing a central sulfonium moiety that showed marginally increased bioactivity compared to commercially available QACs as well as decreased dermal toxicity (Figure 1C).[3234] Reports of simple amphiphilic sulfonium architectures based on commercially available starting materials, however, remain elusive. We therefore sought to design simple sulfonium amphiphiles that could be readily compared to analogous quaternary ammonium amphiphiles analogs to assess potential differences in activity of nitrogen- versus sulfur-based amphiphiles.

For a direct comparison of QACs and TSCs, we targeted structurally simple N-methyl pyrrolidine-based QACs and tetrahydrothiophene-based TSCs. In an initial experiment, N-methyl pyrrolidine (MP) was treated with 1.1 equivalents of dodecyl bromide in acetonitrile at reflux for 24 h, affording monoQAC MP-12 in 88% yield following purification (Scheme 1; see Supporting Information for experimental detail and compound characterization). An analogous procedure was used to synthesize a series of 8 monoQACs, some of which have been previously reported.[35] The resulting MP-n compounds, where n represents the number of carbons in the alkyl chain, were furnished in 43–98 %yield. Given the increased bioactivity of bisQACs compared to monoQACs observed by our group and others,[12,14] we also sought to prepare “bola” amphiphiles bearing a central nonpolar region with polar head groups on either end.[36] To this end, heating 1,8-dibromooctane in neat N-methyl pyrrolidine for 24h afforded bolaQAC MP-8-MP in 95% yield. Using an analogous procedure, we were able to synthesize 2 other bolaQACs, MP-10-MP and MP-12-MP (Scheme 1).

Scheme 1.

Scheme 1.

Synthesis of N-methyl pyrrolidine-based QACs. a) 1.1 equiv CnH2n+1Br, CH3CN, 80 °C, 24 h; b) 0.04 to 0.5 equiv Br–CnH2n–Br, neat, 80 °C, 24 h

With the ammonium-based amphiphiles in hand, we then turned our attention to the synthesis of sulfonium analogues. Our initial attempts of alkylating tetrahydrothiophene (THT) with 1.1 equivalents of dodecyl bromide in acetonitrile at reflux were unsuccessful. However, treatment of dodecyl iodide with a ten-fold excess of tetrahydrothiophene in acetonitrile at reflux led to formation of THT-12 in 55% yield. An analogous procedure was used to synthesize a series of 8 monoTSCs (THT-n) in modest yields. To synthesize compounds analogous to the MP-n-MP series, α,ω-substituted diiodoalkanes were heated with a five-fold excess of tetrahydrothiophene in acetonitrile at reflux for 24 h to give bolaTSCs (THT-n-THT) in 44–87% yield (Scheme 2). An improved, more atom-economical synthesis of THT-based amphiphiles is shown in Scheme 3, with characterization provided in the Supporting Information, taking advantage of an unexpected polar protic solvent, trifluoroacetic acid.[31]

Scheme 2.

Scheme 2.

Synthesis of tetrahydrothiophene-based TSCs. a) 0.1 equiv CnH2n+1I, CH3CN, 80 °C, 24 h; b) 0.2 equiv I–CnH2n–I, CH3CN, 80 °C, 24 h

Scheme 3.

Scheme 3.

Improved synthesis of tetrahydrothiophene-based TSCs. a) 1.1 equiv CnH2n+1Br, trifluoroacetic acid, 73 °C, 24 h; b) 0.5 equiv Br-CnH2n-Br, trifluoroacetid acid, 73 °C, 24 h

With compounds in hand, we sought to compare the biological activities of the ammonium- and sulfonium-based amphiphiles against a range of bacterial strains. Given previously observed similarities in bioactivity of both iodide and bromide salts,[37,38] the initially prepared TSCs with iodide counterions were assessed for bioactivity. Using standard protocols, we assessed both antimicrobial activity and toxicity, using red blood cell (RBC) lysis as a proxy for the latter. The full set of minimum inhibitory concentration (MIC) values against six bacteria [methicillin-susceptible Staphylococcus aureus (MSSA - SH1000), hospital-acquired methicillin-resistant S. aureus (HA-MRSA - ATCC 33591), community-acquired methicillin-resistant S. aureus (CA-MRSA - USA 300), Enterococcus faecalis (OG1RF), Pseudomonas aeruginosa (PA01), and Escherichia coli (MC4100)] and RBC lysis (presented as Lysis20, the highest concentration at which >20% of RBCs are lysed), is shown in Table 1.

Table 1.

Antimicrobial activity and toxicity data for ammonium- and sulfonium-based amphiphiles. [a]

Compound Minimum Inhibitory Concentration (μM) Lysis20 (μM)
MSSA HA-MRSA CA-MRSA E. faecalis P. aeruginosa E. coli

BAC 2 8 2 250 125 32 32
CPC 1 1 1 125 125 32 8

MP-8 >250 >250 >250 >250 >250 >250 125
MP-10 >250 >250 >250 >250 >250 >250 250
MP-11 125 >250 125 >250 >250 >250 125
MP-12 32 125 32 >250 >250 >250 125
MP-13 8 63 16 >250 >250 >250 63
MP-14 4 16 8 >250 >250 250 32
MP-16 4 8 2 >250 >250 125 16
MP-18 2 8 4 >250 250 63 16

MP-8-MP >250 >250 >250 >250 >250 >250 125
MP-10-MP >250 >250 >250 >250 >250 >250 125
MP-12-MP >250 >250 >250 >250 >250 >250 125

THT-8 >250 >250 >250 >250 >250 >250 125
THT-10 250 >250 250 >250 >250 >250 125
THT-11 125 250 250 >250 >250 >250 125
THT-12 16 125 16 >250 >250 >250 125
THT-13 8 125 32 >250 >250 >250 63
THT-14 4 32 4 >250 >250 250 16
THT-16 2 8 4 >250 >250 125 16
THT-18 1 8 4 250 250 63 16

THT-8-THT >250 >250 >250 >250 >250 >250 125
THT-10-THT 250 >250 250 >250 >250 >250 125
THT-12-THT 250 >250 250 >250 >250 >250 250
[a]

Gram-negative bacterial strains P. aeruginosa and E. coli are shaded. All MIC and Lysis20 data were acquired through compilations of the highest value of three independent trials; all trials were within one dilution.

The antimicrobial activity data promised to address a direct question; is there differing activity for amphiphiles built around a sulfonium or an ammonium core? The answer was a resounding no; structurally analogous QACs and TSCs showed remarkably similar activity against all bacterial strains tested. Longer chained monocationic amphiphiles (MP-n and THT-n) were effective against Gram-positive strains, but were less effective against Gram-negative bacterial strains, compared to commercial monoQACs BAC and CPC. These findings are consistent with previous reports showing that TSCs have greater activity against Gram-positive strains compared to Gram-negative strains.[32,33]

Increase in alkyl chain length beyond 14 carbons was necessary to observe good antibacterial activity. The most potent compounds of the series were MP-18 and THT-18, both of which exhibited low micromolar MIC values against MSSA and CA-MRSA strains. This is consistent with other structure-activity studies on monoQACs where activity is best at elongated chain lengths (16–18 carbons).[39] Somewhat unsurprisingly, the biscationic bola compounds (MP-n-MP and THT-n-THT) showed poor activity against all strains tested. This likely results from the structural composition of the bola amphiphiles that contain a short nonpolar region and lack a significant hydrophobic moiety, the latter of which likely contributes to its activity via membrane disruption. The development of longer chained sulfonium-based bola-amphiphiles will be of future interest.

As antibacterial activity increased, hemolytic activity also increased as evidenced by lower Lysis20 values. However, none of the reported compounds were as hemolytic as commercial disinfectant CPC (Lysis20 = 8 μM). The therapeutic indices of the tested commercial ammonium-based disinfectants are similar to that of THT-18. These data point to potential utility of TSCs as alternatives to these traditional ammonium-based antiseptics.

Most compounds tested, except CPC, exhibited decreased activity against HA-MRSA compared to both MSSA and CA-MRSA. The decreased activity of all QACs and TSCs tested against HA-MRSA points to the importance of addressing bacterial resistance in the development of novel disinfectants. Nonetheless, the unique properties of sulfur, including its greater polarizability compared to nitrogen, may be an asset moving forward in addressing the growing concern of bacterial resistance towards commercial QACs.[4,40]

Overall, this work sought to expand the architecture of amphiphilic disinfectants by comparing the activity of sulfonium-based TSCs and structurally analogous QACs. To this end, we synthesized a series of QACs and TSCs based on N-methyl pyrrolidine and tetrahydrothiophene nucleophiles, respectively. A comparison of the bioactivity profiles of these compounds revealed striking similarities in activity against Gram-positive strains, with THT-18 as the best compound overall with low micromolar MICs against both MSSA and CA-MRSA, as well as therapeutic indices similar to commercial disinfectants tested. The bioactivity profile of MP-18 and THT-18 against Gram-positive strains is comparable to commercial disinfectant BAC. Given the overall similarities in bioactivity between the synthesized QACs and TSCs, further study is warranted into TSCs to expand our current library of disinfectants to combat bacterial infections and the rapid development of bacterial resistance to commercial disinfectants. In light of the superior activity of bisQACs versus traditional ammonium amphiphiles, bisTSCs represent an area ripe for exploration.

Supplementary Material

1

Acknowledgments

This work was funded by the National Institute of General Medical Sciences (R35 GM119426 to W.M.W.) and a Major Research Instrumentation grant from the National Science Foundation (CHE-1827930 to K.P.C.M.). C.L.S. was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number T32AI106699. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • 1.Domagk G Eine Neue Klasse von Desinfektionsmitteln. Dtsch. Medizinische Wochenschrift 1935, 61 (21), 829–832. [Google Scholar]
  • 2.PRICE PB BENZALKONIUM CHLORIDE (ZEPHIRAN CHLORIDE®) AS A SKIN DISINFECTANT. JAMA Surg 1950, 61 (1), 23–33. [DOI] [PubMed] [Google Scholar]
  • 3.Denyer SP Mechanisms of Action of Antibacterial Biocides. Int. Biodeterior. Biodegrad 1995, 36 (3–4), 227–245. [Google Scholar]
  • 4.C. Jennings M; P. C. Minbiole K; M. Wuest W ACS Infect. Dis 2015, 1 (7), 288–303. [DOI] [PubMed] [Google Scholar]
  • 5.Haldar J; Kondaiah P; Bhattacharya S. J. Med. Chem 2005, 48 (11), 3823–3831. [DOI] [PubMed] [Google Scholar]
  • 6.Brycki B; Małecka I; Koziróg A; Otlewska A Molecules 2017, 22 (1), 130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Faig A; Arthur TD; Fitzgerald PO; Chikindas M; Mintzer E; Uhrich KE Langmuir 2015, 31 (43), 11875–11885. [DOI] [PubMed] [Google Scholar]
  • 8.Laverty G; Gorman SP; Gilmore BF Int. J. Mol. Sci 2011, 12 (10), 6566–6596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang N; Ma S European Journal of Medicinal Chemistry. Elsevier Masson SAS; December 15, 2019, p 111743. [DOI] [PubMed] [Google Scholar]
  • 10.Bazina L; Maravić A; Krce L; Soldo B; Odžak R; Popović VB; Aviani I; Primožič I; Šprung MD Eur. J. Med. Chem 2019, 163, 626–635. [DOI] [PubMed] [Google Scholar]
  • 11.Palermo EF; Vemparala S; Kuroda K Biomacromolecules 2012, 13 (5), 1632– [DOI] [PubMed] [Google Scholar]
  • 12.Minbiole KPC; Jennings MC; Ator LE; Black JW; Grenier MC; LaDow JE; Caran KL; Seifert K; Wuest WM. Tetrahedron 2016, 72 (25), 3559–3566. [Google Scholar]
  • 13.Morrison KR; Allen RA; Minbiole KPC; Wuest WM Tetrahedron Lett 2019, 60 (37), 150935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kanazawa A; Ikeda T; Endo T Antimicrob. Agents Chemother 1994, 38 (5), 945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lukáč M; Devínsky F; Pisárčik M; Papapetropoulou A; Bukovský M; Horváth BJ Surfactants Deterg 2017, 20 (1), 159–171. [Google Scholar]
  • 16.Brunel F; Lautard C; di Giorgio C; Garzino F; Raimundo JM; Bolla JM; Camplo M Bioorganic Med. Chem. Lett 2018, 28 (5), 926–929. [DOI] [PubMed] [Google Scholar]
  • 17.Terekhova NV; Tatarinov DA; Shaihutdinova ZM; Pashirova TN; Lyubina AP; Voloshina AD; Sapunova AS; Zakharova LY; Mironov VF Bioorganic Med. Chem. Lett 2020, 30 (13), 127234. [DOI] [PubMed] [Google Scholar]
  • 18.Li L; Zhou H; Gai F; Chi X; Zhao Y; Zhang F; Zhao Z RSC Adv 2017, 7 (22), 13244–13249. [Google Scholar]
  • 19.Carden RG; Sommers KJ; Schrank CL; Leitgeb AJ; Feliciano JA; Wuest WM; Minbiole KPC. ChemMedChem 2020, 15, 1974–1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rhodes D; Hanson AD. Annu. Rev. Plant Physiol. Plant Mol. Biol 1993, 44 (1), 357–384. [Google Scholar]
  • 21.Cantoni GL J. Am. Chem. Soc 1952, 74 (11), 2942–2943. [Google Scholar]
  • 22.Mischoulon D; Alpert JE; Arning E; Bottiglieri T; Fava M; Papakostas GI. J. Clin. Psychiatry 2012, 73 (06). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ringdahl E; Pandit S Treatment of Knee Osteoarthritis; 2011; Vol. 83. [PubMed] [Google Scholar]
  • 24.Mato JM; Martínez-Chantar ML; Lu SC Annals of Hepatology. Fundacion Clinica Medica Sur; 2013, pp 183–189. [PMC free article] [PubMed] [Google Scholar]
  • 25.Fetrow CW; Avila JR Annals of Pharmacotherapy. Harvey Whitney Books Company; November 28, 2001, pp 1414–1425. [DOI] [PubMed] [Google Scholar]
  • 26.Klimenko SK; Stolbova TV; Kulikova LK. Pharm. Chem. J 2001, 35 (1), 22–25. [Google Scholar]
  • 27.Klimenko SK; Stolbova TV; Kulikova LK; Shub GM. Pharm. Chem. J 2001, 35 (7), 370–372. [Google Scholar]
  • 28.Nikolaev AE; Semenov VÉ; Voloshina AD; Kulik NV; Reznik VS. Pharm. Chem. J 2010, 44 (3), 130–133. [Google Scholar]
  • 29.Bakhtiyarova YV; Bakhtiyarov DI; Ivshin KA; Galkina IV; Krasnyuk II; Gerasimov AV; Kataeva ON; Galkin VI. Russ. J. Gen. Chem 2017, 87 (9), 1903–1907. [Google Scholar]
  • 30.Guan D; Chen F; Qiu Y; Jiang B; Gong L; Lan L; Huang W. a. Angew. Chemie Int. Ed 2019, 58 (20), 6678–6682. [DOI] [PubMed] [Google Scholar]
  • 31.Li L; Jia D; Wang H; Chang C; Yan J; Zhao ZK New J. Chem 2020, 44 (2), 303–307. [Google Scholar]
  • 32.Hirayama M Biocontrol Sci 2011, 16 (1), 23–31 [DOI] [PubMed] [Google Scholar]
  • 33.Hirayama M. Biocontrol Sci 2011, 16 (4), 149–158. [DOI] [PubMed] [Google Scholar]
  • 34.Hirayama M Biocontrol Sci 2012, 17 (1), 27–35. [DOI] [PubMed] [Google Scholar]
  • 35.Qin J; Guo J; Xu Q; Zheng Z; Mao H; Yan F ACS Appl. Mater. & Interfaces 2017, 9 (12), 10504–10511. [DOI] [PubMed] [Google Scholar]
  • 36.Fuhrhop JH; Wang T Bolaamphiphiles. Chem. Rev 2004, 104 (6), 2901–2937. [DOI] [PubMed] [Google Scholar]
  • 37.Grenier MC; Davis RW; Wilson-Henjum KL; Ladow JE; Black JW; Caran KL; Seifert K; Minbiole KPC. Bioorganic Med. Chem. Lett 2012, 22 (12), 4055–4058. [DOI] [PubMed] [Google Scholar]
  • 38.Kontos RC; Schallenhammer SA; Bentley BS; Morrison KR; Feliciano JA; Tasca JA; Kaplan AR; Bezpalko MW; Kassel WS; Wuest WM; Minbiole KPC. ChemMedChem 2019, 14 (1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Joyce MD; Jennings MC; Santiago CN; Fletcher MH; Wuest WM; Minbiole KP. J. Antibiot. (Tokyo). 2016, 69 (4), 344–347. [DOI] [PubMed] [Google Scholar]
  • 40.C. Jennings M; A. Buttaro B; P. C. Minbiole K; M. Wuest W. ACS Infect. Dis 2015, 1 (7), 304–309. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES